Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IGTM-101 in Advanced Melanoma
NCT03338777Phase 1Terminated
- Sponsor
- Hospital Italiano de Buenos Aires
- Start
- Feb 2020
- Primary completion
- Feb 2020
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in melanoma, sponsored by Hospital Italiano de Buenos Aires. Primary endpoint: Safety reported as the number of treatment-related adverse events at 1 year. Started Feb 2020; status: terminated.
02
Conditions
melanoma
Beyond the preview
Go deeper on NCT03338777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03338777.